Navigation Links
Greenberg Traurig's New York Office Expands Health Care Practice With Addition of Francis Serbaroli
Date:12/3/2008

NEW YORK, Dec. 3 /PRNewswire/ -- Francis J. Serbaroli has joined the international law firm Greenberg Traurig, LLP in its New York City office as a shareholder in the Health and FDA Business Practice Group. Serbaroli joins Greenberg Traurig from Cadwalader, Wickersham & Taft LLP. He has also served as a member of the New York State Public Health Council for more than 13 years.

Serbaroli, who has nearly three decades of industry experience, will expand Greenberg Traurig's health care practice in New York State. Serbaroli represents health plans, hospitals, nursing homes and home care providers, clinics as well as clinical laboratories and renal dialysis providers, and other health care companies. He handles a wide range of corporate, regulatory, compliance, corporate governance and litigation matters for these clients. He also advises numerous companies in connection with the prohibitions on the corporate practice of medicine and fee-splitting.

Members of the Public Health Council are nominated by the Governor and confirmed by the New York State Senate. Serbaroli is currently serving his third term as a Council Member.

"Frank is a valuable and unique addition to the firm," said Harold N. Iselin, leader of its New York State health care practice and Managing Shareholder of Greenberg Traurig's Albany office. "His arrival marks the expansion of our New York State health care practice and makes us one of a few firms with attorneys specializing in this area in both Albany and New York City. It is our goal that our clients will benefit from Frank's extensive a
'/>"/>

SOURCE Greenberg Traurig, LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Yugma Appoints Vas Bhandarkar as Chief Executive Officer
2. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
3. Employees Have Yet Another Reason To Lose Their Office Chairs In Favor Of A Treadmill Desk: Their Brain
4. TYRX Appoints David Elliot, Jr. Chief Operating Officer
5. Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
6. Streamline Health Announces Appointment of Interim Chief Financial Officer
7. SimQuest Awarded Phase 2 Contract from Office of the Secretary of Defense to Develop Pandemic Influenza Training Program
8. Law Offices of Howard G. Smith Announces Class Action Lawsuit on Behalf of Investors of PharmaNet Development Group, Inc.
9. MassMutual Announces Promotions for Two Co-Chief Operating Officers
10. Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer
11. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ger the drug used, the greater the sleep disturban...HealthDay News) -- The widely used club drug ecsta...y U.S. researchers. , "People who use ecstasy n...an cause immediate and dangerous problems such as ...Johns Hopkins School of Medicine in Baltimore, sai...
(Date:12/2/2009)..., PASADENA, Calif., Dec. 2 /PRNewswire-USNewswir...m has received the Gold Seal of Approval from the ...ry stroke center. This means Huntington will join... throughout Los Angeles County. ,, "This is a...important, a wonderful benefit for Pasadena and it...
(Date:12/2/2009)... , New Directors Represent Divers.... 2 The membership of t...embers to its Board of Directors and reappointed f...epresent a wide range of healthcare stakeholders, ...pliers, and public and community healthcare. ,...
(Date:12/2/2009)... , Ruling by federal government ends ni...LOS ANGELES, Dec. 2 Mor... Kaiser Permanente facilities across Southern Cali...the National Union of Healthcare Workers (NUHW). ,...join NUHW in February, but SEIU delayed the electi...
(Date:12/2/2009)...ate cancer patients who have a prostate-specific a... two years after external beam radiation therapy (...and cancer-related death, according to a study in ...of Radiation Oncology*Biology*Physics, the officia...cology (ASTRO)., PSA levels in a prostate cancer...
Breaking Medicine News(10 mins):Health News:Ecstasy Users at Higher Risk of Sleep Apnea 2Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2
...ALT LAKE CITY, March 31 Dynatronics Corporation (...iled a third grace period extension with the SEC, ...7, 2009, to comply with NASDAQ,s $1 per share mini...t of Dynatronics. "This will allow us time to anno...
...The International Association for Dental Research ...onal Institute of Allergy and Infectious Diseases ...thesda, Md., USA as 2009 IADR Honorary Membership ...e director of NIAID, where he oversees an extensiv...
...AUGUSTA, Ga. A failing heart makes a lot of a hor... bloating the body but not enough of the enzyme ne...vel assays they developed, Medical College of Geor...ade by heart muscle cells that, when active, helps...
...AN FRANCISCO, March 31 Pacific Fertility Center i...er using preimplantation genetic diagnosis (PGD) a...t media attention about "designer babies" mentione...ility Center is proud to have been a pioneer in th...
...RINCETON, N.J., March 31 Americans, financial sec...ir willingness to make spending cuts. While nearly...ise their standard of living, the other half see l...sults of the 2009 Economic Impact Market Segmentat...
... MINNEAPOLIS, March 31 Five local organizations...art disease and high cholesterol,in Hispanic commu...zon grants,to continue on their mission. Chosen f...ided excellent resources to help raise,the level o...
Other Medicine News:Health News:NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance 2Health News:New tests provide new insight into why patients are in heart failure 2Health News:New tests provide new insight into why patients are in heart failure 3Health News:PGD Technology Offers More Than Designer Babies 2Health News:PGD Technology Offers More Than Designer Babies 3Health News:PGD Technology Offers More Than Designer Babies 4Health News:New Study Shows That Despite Recession, Consumer 'Hold-Outs' Struggle To Have It All 2Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 2Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 3Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 4
(Date:12/2/2009)...e-FirstCall/ -- Cardinal Health today announced th... directors, effective immediately. ,, Cox, 52, ...nd president of global pharmaceuticals at Schering...mpany at the close of its merger with Merck last m... Cox served as president of Pharmacia Corp.,s glob...
(Date:12/2/2009)...ecember 2 DermaGen AB - part of th...ling company "Pergamum" -,today announced that Der...nical Phase I/IIa study. DermaGen AB is developing... atopic dermatitis. Atopic dermatitis is a chronic...skin,s weakened barrier,function make patients sus...
(Date:12/2/2009)...er 2 Cardio Vascular,Med...f advanced,cardiovascular surgery technology, toda...approved a one-for-three forward stock split, in t...cular Medical Device shareholders. , The ...date the stock,split will be payable and the relat...
Breaking Medicine Technology:Cardinal Health Names Carrie Cox to Board of Directors 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 1NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 2NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 3NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 4UK Smoking Ban Fuels Rise In Surgery 51391 1UK Smoking Ban Fuels Rise In Surgery 51391 2Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 1Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 2Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 3
...pt. 11 S*BIO Pte Ltd today announced the,developm... compound,SB1518, for the treatment of myeloprolif...malignancies. MPD is believed to be caused by a sp...elated group of hematological,malignancies in whic...y.,MPD is characterised by an excess of blood cell...
...trates Safety and Tolerability with No Clinically ...nts- -Conference Call Scheduled for 8:30...sset, Inc.,(Nasdaq: VRUS ) is presenting safety, ... following single ascending doses of R7128 at the ...and Related Viruses being held,from September 9-13...
Other Medicine Technology:S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 3Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 4Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 5
CHECK-FLO Performer Introducer Sets
TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
Wiseguide Guide Catheter
Convoy Catheter Introducer Sheaths
Medicine Products: